Glenmark Pharma's wait for licencing deal ends

  • 2:39
  • Published On: May 03, 2010
Cinema View
Embed
The year-long wait for Glenmark Pharmaceuticals to cut a licencing deal is finally over. The company partners with Sanofi-Aventis to develop and commercialise Glenmark's novel molecules for pain treatment led by GRC 15300

Related Videos

Big Drug Haul In Chennai, Cocaine, MDMA Seized Worth Rs 22 Crore
May 16, 2024 2:38
Taj Group Enters Luxury Residences Business. First Project In Chennai
May 16, 2024 6:57
Rakesh Jhunjhunwala's Wife Loses Rs 800 Crore As Her Biggest Stock Bet Tanks
May 08, 2024 1:06
Meet The Woman Who Built Her Six-Figure Food Business After Getting Laid Off
May 01, 2024 7:46
Drugs Worth Rs 600 Crore, 14 Pakistanis Caught In Massive Op On The Sea
April 28, 2024 1:06
Kutch's Textile Craft Ajrakh Gets Geographical Indication Tag
April 28, 2024 2:31
Many Drug Manufacturing Labs Busted By NCB, ATS & Gujarat Police
April 27, 2024 0:42
What Does Launch Of Derivative Contracts On Nifty Next 50 Mean For You?
April 24, 2024 5:51
Poppy Straw Seized In Hyderabad, 2 Arrested
April 21, 2024 3:36
Madhya Pradesh's Tuberculosis Drug Shortage Could Impact Over A Lakh Patients
April 18, 2024 3:06
"Tesla Factory In India Will Be Game-Changer": Ex-Chief Economic Advisor To NDTV
April 18, 2024 5:10
Sensex Crosses 75,000-Mark In Historic Milestone For Share Market
April 09, 2024 3:36
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination